ROBO1-specific CAR-NK cells

· Asclepius Technology Company Group (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ROBO1-specific CAR-NK cells, covering 2019-05-07 to 2019-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors [Phase 1, Phase 2]